Evaluation of Barij blood pressure syrup products in patients with hypertension

Evaluation of Barij blood pressure syrup products in patients with hypertension: a double blind randomized placebo controlled trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170112031893N1

Enrollment

Registered

2018-04-07

Start date

2018-04-21

Completion date

Unknown

Last updated

2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension. Essential (primary) hypertension

Interventions

Intervention 1: Intervention group: Barij syrup. (A natural combination of chicory, tangerine, malt extract, sesame, sour lemon, sweet almond produced by Barij company ) 30 ml oral Barij syrup is admi

Eligibility

Sex/Gender

All

Age

25 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patient with stage I hypertension (Systolic Blood Pressure (SBP) 140-159 mmHg, Diastolic Blood Pressure (DBP) 90-99 mmHg) and not using a particular anti-hypertensive therapy

Exclusion criteria

Exclusion criteria: Pregnant women or women planning to get pregnant Being allergic to Barij syrups Suffering from intestinal diseases such as Crohn's disease, colitis, peptic ulcer, irritable bowel syndrome (IBS) History of myocardial infarction; coronary bypass surgery during last 6 month

Design outcomes

Primary

Measure	Time frame
Systolic blood pressure. Timepoint: Prior to study, second week, fourth week , eighth week and at the end of study. Method of measurement: In mmHg using mercuric manometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein moradi

Ghoum University of Medical Sciences

moradi.medicine@yahoo.com+98 25 3770 7843

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026